118 research outputs found

    Dopant Spatial Distributions: Sample Independent Response Function And Maximum Entropy Reconstruction

    Full text link
    We demonstrate the use of maximum entropy based deconvolution to reconstruct boron spatial distribution from the secondary ion mass spectrometry (SIMS) depth profiles on a system of variously spaced boron δ\delta-layers grown in silicon. Sample independent response functions are obtained using a new method which reduces the danger of incorporating real sample behaviour in the response. Although the original profiles of different primary ion energies appear quite differently, the reconstructed distributions agree well with each other. The depth resolution in the reconstructed data is increased significantly and segregation of boron at the near surface side of the δ\delta-layers is clearly shown.Comment: 5 two-columne pages, 3 postscript figures, to appear in Phys. Rev. B1

    Processing and evaluation of dissimilar Al-SS friction welding of pipe configuration : nondestructive inspection, properties, and microstructure

    Get PDF
    In the present investigation, dissimilar friction welding between AA6063-T6 and SS 304L materials of pipe joint configuration with an outer diameter of 88.90 mm and a wall thickness of 5.4 mm was performed. Four different experimental conditions were varied based on visual inspection after each weld. The welded pipe joints were evaluated by vacuum leak detection, thermal shock test, pneumatic pressure test, tensile test, optical and scanning electron microscopy, energy dispersive X-ray spectroscopy, X-ray diffractions, X-ray elemental mapping, and hardness measurements. The results revealed that friction welded Al-SS bimetallic pipes sustained ultra-high vacuum pressure and cryogenic working environments without leak detection. Al-SS friction welded pipe resulted in high tensile strength with 72% of joint efficiency as compared to AA6063-T6 base material. Microstructure variations were observed significant towards AA6063-T6 material close to the Al-SS interface. The intermetallic compound of Fe3Al phase was identified with a reaction layer between Al-SS joints with varying thickness of 1.1 µm to 2.0 µm

    Friction welding of dissimilar joints copper-stainless steel pipe consist of 0.06 wall thickness to pipe diameter ratio

    Get PDF
    This paper examines dissimilar friction welding between electrolytic tough pitch copper (ETP-Cu) and stainless steel (SS) of grade 304 L for pipe joint configuration, having 0.06 wall thickness to pipe diameter ratio. The welding is performed using the continuous drive friction welding method. The welded joint is evaluated by visual inspection, leak-proof ability by helium leak detection testing, microstructure features by optical and scanning electron microscopy, energy dispersive x-ray spectroscope, x-ray diffraction patterns, tensile testing, and hardness measurements. The continuity of welding is evaluated by peripheral inspection and testing on four different locations of pipe welded joint. The results revealed that sound joints between dissimilar materials of Cu-SS are established with evidence of resistance to leak at room temperature and after cryogenic shock test. The Cu-SS pipe joint received excellent strength of 242.48 N/mm2, which is nearly 80% of ETP-Cu base material. The microstructure changes are distinctly observed at the Cu side, whereas no significant microstructure changes are observed at the SS side. The microstructure features are consisting of full dynamic recrystallization zone and partial dynamic recrystallization zone that are identified at the Cu side. However, no adverse effect of microstructure on tensile strength and hardness is observed. The weld continuity in the periphery of pipe configuration is observed at four different locations. A continuous reaction layer at four investigated locations is identified, with the presence of Cu and Fe elements at the joint interface

    Microstructure evolution and mechanical properties of continuous drive friction welded dissimilar copper-stainless steel pipe joints

    Get PDF
    In the present investigation, the microstructure evolution and mechanical properties of dissimilar materials Copper-Stainless Steel pipe joints welded by continuous drive friction welding under two different processing conditions are analyzed. The processing conditions of friction welding for copper-stainless steel joints are varied by two friction times of 10 s and 15 s while keeping other processing parameters constant. The welded specimens are analyzed for materials characterizations and mechanical testing using optical microscopy and scanning electron microscopy, electron dispersive x-ray spectroscopy, electron backscatter diffraction analysis, X-ray diffractions, tensile testing, and microhardness measurements. The results revealed that the major microstructural evolution is observed at the Cu side with dynamic recrystallized zones. Enhanced metallurgical bonding between Cu-SS materials is obtained with microstructural evolutions (such as full dynamic recrystallized zone at Cu side and quenching zone at SS side) near to Cu-SS interface, in case of weld made by friction time of 15 s. Superior interatomic diffusion leading to enhanced metallurgical bonding is evidenced for weld made by friction time of 15 s. The reaction layer thickness influences the bonding and mechanical properties of Cu-SS friction welds. The reaction layer thickness of 17.28 μm is observed for the weld made by friction time of 10 s, whereas the reaction layer thickness of 1.21 μm is observed for the weld made by friction time of 15 s. The ultimate tensile strength of 181.05 MPa is obtained for Cu-SS friction weld

    Improvement of the machining performance of the TW-ECDM process using magnetohydrodynamics (MHD) on quartz material

    Get PDF
    Many microslits are typically manufactured on quartz substrates and are used to improve their industrial performance. The fabrication of microslits on quartz is difficult and expensive to achieve using recent traditional machining processes due to its hardness, electrically insulating nature, and brittleness. The key objective of the current study was to demonstrate the fabrication of microslits on quartz material through a magnetohydrodynamics (MHD)-assisted traveling wire-electrochemical discharge micromachining process. Hydrogen gas bubbles were concentrated around the entire wire surface during electrolysis. This led to a less active dynamic region of the wire electrode, which decreased the adequacy of the electrolysis process and the machining effectiveness. The test results affirmed that the MHD convection approach evacuated the gas bubbles more rapidly and improved the void fraction in the gas bubble scattering layer. Furthermore, the improvements in the material removal rate and length of the cut were 85.28% and 48.86%, respectively, and the surface roughness was reduced by 30.39% using the MHD approach. A crossover methodology with a Taguchi design and ANOVA was utilized to study the machining performance. This exploratory investigation gives an unused strategy that shows a few advantages over the traditional TW-ECDM process

    Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

    Get PDF
    Background: Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently recommended treatments. Methods: The Best Available Treatment Study evaluated immunomodulatory treatments for MIS-C in an international observational cohort. Analysis of the first 614 patients was previously reported. In this propensity-weighted cohort study, clinical and outcome data from children with suspected or proven MIS-C were collected onto a web-based Research Electronic Data Capture database. After excluding neonates and incomplete or duplicate records, inverse probability weighting was used to compare primary treatments with intravenous immunoglobulin, intravenous immunoglobulin plus glucocorticoids, or glucocorticoids alone, using intravenous immunoglobulin as the reference treatment. Primary outcomes were a composite of inotropic or ventilator support from the second day after treatment initiation, or death, and time to improvement on an ordinal clinical severity scale. Secondary outcomes included treatment escalation, clinical deterioration, fever, and coronary artery aneurysm occurrence and resolution. This study is registered with the ISRCTN registry, ISRCTN69546370. Findings: We enrolled 2101 children (aged 0 months to 19 years) with clinically diagnosed MIS-C from 39 countries between June 14, 2020, and April 25, 2022, and, following exclusions, 2009 patients were included for analysis (median age 8·0 years [IQR 4·2–11·4], 1191 [59·3%] male and 818 [40·7%] female, and 825 [41·1%] White). 680 (33·8%) patients received primary treatment with intravenous immunoglobulin, 698 (34·7%) with intravenous immunoglobulin plus glucocorticoids, 487 (24·2%) with glucocorticoids alone; 59 (2·9%) patients received other combinations, including biologicals, and 85 (4·2%) patients received no immunomodulators. There were no significant differences between treatments for primary outcomes for the 1586 patients with complete baseline and outcome data that were considered for primary analysis. Adjusted odds ratios for ventilation, inotropic support, or death were 1·09 (95% CI 0·75–1·58; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids and 0·93 (0·58–1·47; corrected p value=1·00) for glucocorticoids alone, versus intravenous immunoglobulin alone. Adjusted average hazard ratios for time to improvement were 1·04 (95% CI 0·91–1·20; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids, and 0·84 (0·70–1·00; corrected p value=0·22) for glucocorticoids alone, versus intravenous immunoglobulin alone. Treatment escalation was less frequent for intravenous immunoglobulin plus glucocorticoids (OR 0·15 [95% CI 0·11–0·20]; p<0·0001) and glucocorticoids alone (0·68 [0·50–0·93]; p=0·014) versus intravenous immunoglobulin alone. Persistent fever (from day 2 onward) was less common with intravenous immunoglobulin plus glucocorticoids compared with either intravenous immunoglobulin alone (OR 0·50 [95% CI 0·38–0·67]; p<0·0001) or glucocorticoids alone (0·63 [0·45–0·88]; p=0·0058). Coronary artery aneurysm occurrence and resolution did not differ significantly between treatment groups. Interpretation: Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and limited availability of intravenous immunoglobulin in many countries. Funding: Imperial College London, the European Union's Horizon 2020, Wellcome Trust, the Medical Research Foundation, UK National Institute for Health and Care Research, and National Institutes of Health

    Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

    Get PDF
    Background: Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently recommended treatments. Methods: The Best Available Treatment Study evaluated immunomodulatory treatments for MIS-C in an international observational cohort. Analysis of the first 614 patients was previously reported. In this propensity-weighted cohort study, clinical and outcome data from children with suspected or proven MIS-C were collected onto a web-based Research Electronic Data Capture database. After excluding neonates and incomplete or duplicate records, inverse probability weighting was used to compare primary treatments with intravenous immunoglobulin, intravenous immunoglobulin plus glucocorticoids, or glucocorticoids alone, using intravenous immunoglobulin as the reference treatment. Primary outcomes were a composite of inotropic or ventilator support from the second day after treatment initiation, or death, and time to improvement on an ordinal clinical severity scale. Secondary outcomes included treatment escalation, clinical deterioration, fever, and coronary artery aneurysm occurrence and resolution. This study is registered with the ISRCTN registry, ISRCTN69546370. Findings: We enrolled 2101 children (aged 0 months to 19 years) with clinically diagnosed MIS-C from 39 countries between June 14, 2020, and April 25, 2022, and, following exclusions, 2009 patients were included for analysis (median age 8·0 years [IQR 4·2–11·4], 1191 [59·3%] male and 818 [40·7%] female, and 825 [41·1%] White). 680 (33·8%) patients received primary treatment with intravenous immunoglobulin, 698 (34·7%) with intravenous immunoglobulin plus glucocorticoids, 487 (24·2%) with glucocorticoids alone; 59 (2·9%) patients received other combinations, including biologicals, and 85 (4·2%) patients received no immunomodulators. There were no significant differences between treatments for primary outcomes for the 1586 patients with complete baseline and outcome data that were considered for primary analysis. Adjusted odds ratios for ventilation, inotropic support, or death were 1·09 (95% CI 0·75–1·58; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids and 0·93 (0·58–1·47; corrected p value=1·00) for glucocorticoids alone, versus intravenous immunoglobulin alone. Adjusted average hazard ratios for time to improvement were 1·04 (95% CI 0·91–1·20; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids, and 0·84 (0·70–1·00; corrected p value=0·22) for glucocorticoids alone, versus intravenous immunoglobulin alone. Treatment escalation was less frequent for intravenous immunoglobulin plus glucocorticoids (OR 0·15 [95% CI 0·11–0·20]; p<0·0001) and glucocorticoids alone (0·68 [0·50–0·93]; p=0·014) versus intravenous immunoglobulin alone. Persistent fever (from day 2 onward) was less common with intravenous immunoglobulin plus glucocorticoids compared with either intravenous immunoglobulin alone (OR 0·50 [95% CI 0·38–0·67]; p<0·0001) or glucocorticoids alone (0·63 [0·45–0·88]; p=0·0058). Coronary artery aneurysm occurrence and resolution did not differ significantly between treatment groups. Interpretation: Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and limited availability of intravenous immunoglobulin in many countries. Funding: Imperial College London, the European Union's Horizon 2020, Wellcome Trust, the Medical Research Foundation, UK National Institute for Health and Care Research, and National Institutes of Health
    corecore